CClinicalTrials.gg
CompletedNCT02751840RMRUpdated Apr 27, 2016

Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men

A Phase 3 interventional study of Caffeine and Placebo in Asymptomatic Conditions, sponsored by Tel Hai College. Completed. Open to male participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-27.

Sponsored by Tel Hai College · Phase 3, Interventional, and Basic science

Phase
Phase 3
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
Male
01

Study summary

Background. The prevalence of obesity has increased in the last two decades. To maintain body weight energy expenditure (EE) should be equal to energy intake (EI). A low EE predisposes individuals to weight gain and to obesity that can also results from low resting metabolic rate (RMR). Caffeine (Caf) is an active food ingredient and is widely consumed globally, and has an important impact on energy balance. Caf reduces appetite (EI) and increases EE, thus, Caf has a potential role in body weight reduction. Caf causes higher total daily energy expenditure (TDEE) in normal weight (NW) people compared to obese (OW). Moreover Caf is linked to decreased fat oxidation in OW. There are differences between OW and NW in Caf pharmacokinetics, but no differences reported between NW and OW females in its effects on RMR. There is a gender difference in the influence of Caf on metabolism. The investigators are aware of no previous studies which compared the effect of Caf on the RMR of NW and OW men.

Objectives. 1) To compare the effect of Caf and coffee on resting metabolic rate (RMR) values in healthy normal-weight (NW) men and overweight (OW) men. 2) To develop Caf intake frequency questionnaire (in Hebrew)

Hypothesis. RMR values will be higher and respiratory exchange ratio (RER) values will be lower in NW compared to the values measured in OW men.

Methods. 33 men (16 NW and 17 OW) were reported to the laboratory on 4 separate occasions (placebo, Caf tablets, coffee and decaffeinated coffee). During the lab sessions they were undergo complete anthropometric measurements and RMR measured (one of the study conditions) using indirect calorimetry. Additionally, respiratory exchange ratio (RER) which is calculated as the ratio between CO2 production (VCO2) and O2 consumption (VO2) (VCO2/VO2), blood pressure and heart rate (HR) response recorded.

The importance of this study is that the results will contribute to the scientific basis of weight control and health interventions programs (diet and physical activity) in overweight men.

Read the detailed description

Methods. 16 NW and 17 OW men were reported to the laboratory on 4 separate occasions (placebo, Caf tablets, coffee and decaffeinated coffee) each separated by 2-7 days. Before the first meeting they refill caffeine, physical activity and medical questionnaires. The investigators recruited only men who were healthy non-smokers with no comorbidities and the daily caffeine consumption was under 400 mg. Before each meeting participants had to comply guidelines outlined included fasting for 8 hours, avoiding intense physical activity 14 hours and moderate exercise 2 hours before measurements. The meetings conducted in the morning when the first session included anthropometric measurements (weight, height and waist circumference) and body composition measurements using Bioelectrical Impedance Analysis (BIA) and a digital caliper. Each session began with a measuring resting blood pressure and heart rate (Polar telemetric systems), after that participants were given randomly placebo or Caf tablets or coffee or decaffeinated coffee, waiting half an hour and then measuring the RMR and respiratory exchange ratio (RER), for half an hour using indirect calorimetry (canopy system). Then again measured blood pressure and heart rate at rest.

The sample size was calculated for 16 participant in each group, according to an expected change of 3% at RMR values between the groups with the power of 80% and significance of 0.05 . standard deviation (SD).

02

Conditions studied

  • Asymptomatic Conditions

Browse trials for

03

In context

Asymptomatic Diseases

36 studies on the registry are indexed under Asymptomatic Diseases; 8 are open to participants now.

This study's enrollment of 33 is below the median of 50 across 26 interventional studies indexed under Asymptomatic Diseases.

Browse Asymptomatic Diseases studies →

Lead sponsor

Tel Hai College is the lead sponsor of 18 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

33 Healthy men at the age between 20-50 years. 16 normal weight men and 17 obese men.

Exclusion criteria

Exclusion Criteria:

  1. Hypertension (above 140/90 mmHg)
  2. Taking medications for hypertension
  3. Heart, liver or kidney problems, diabetes, respiratory problems, hypo/hyper thyroidism.
  4. Smoking
  5. Men who consume caffeine above 400 mg/day
  6. Taking medications or dietary supplements that can affect energy expenditure
  7. Elite athletes (competitive sport)
  8. Night Eating
05

Study design

Phase
Phase 3
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Caffeine

    Caffeine capsule (200 mg) is taken prior to RMR measurement

    Dietary Supplement: Caffeine · Dietary Supplement: Placebo · Other: Coffee · Other: Decaffeinated

  • Placebo comparator
    Placebo

    Placebo (starch) capsule is taken prior to RMR measurement

    Dietary Supplement: Caffeine · Dietary Supplement: Placebo · Other: Coffee · Other: Decaffeinated

  • Experimental
    Coffee

    Black coffee (9 grams) is consumed prior to RMR measurement

    Dietary Supplement: Caffeine · Dietary Supplement: Placebo · Other: Coffee · Other: Decaffeinated

  • Placebo comparator
    Decaffeinated

    Decaffeinated Black coffee (9 grams) is consumed prior to RMR measurement

    Dietary Supplement: Caffeine · Dietary Supplement: Placebo

Interventions

  • Dietary supplementCaffeine

    200 mg of caffeine capsule before RMR measurement

  • Dietary supplementPlacebo

    Placebo capsule (starch) before RMR measurement

  • OtherCoffee

    9 grams of black coffee in boiling water consumed before RMR measurement

  • OtherDecaffeinated

    9 grams of decaffeinated black coffee in boiling water consumed before RMR measurement

06

What researchers measure

Primary outcomes

  1. Measurement of resting metabolic expenditure using indirect calorimetry (open flow canopy system)

    Time frame: Within two weeks (4 sessions, each 30 minutes)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980 May;33(5):989-97. doi: 10.1093/ajcn/33.5.989. PubMed 7369170 ↗
  • Adan A, Prat G, Fabbri M, Sanchez-Turet M. Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1698-703. doi: 10.1016/j.pnpbp.2008.07.005. Epub 2008 Jul 15. PubMed 18675877 ↗
  • Bracco D, Ferrarra JM, Arnaud MJ, Jequier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol. 1995 Oct;269(4 Pt 1):E671-8. doi: 10.1152/ajpendo.1995.269.4.E671. PubMed 7485480 ↗
  • Jeukendrup AE, Randell R. Fat burners: nutrition supplements that increase fat metabolism. Obes Rev. 2011 Oct;12(10):841-51. doi: 10.1111/j.1467-789X.2011.00908.x. PubMed 21951331 ↗
  • Temple JL, Ziegler AM. Gender Differences in Subjective and Physiological Responses to Caffeine and the Role of Steroid Hormones. J Caffeine Res. 2011 Mar;1(1):41-48. doi: 10.1089/jcr.2011.0005. PubMed 24761262 ↗
  • Pohanka M. The perspective of caffeine and caffeine derived compounds in therapy. Bratisl Lek Listy. 2015;116(9):520-30. doi: 10.4149/bll_2015_106. PubMed 26435014 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02751840
Lead sponsor
Tel Hai College
Responsible party
Sponsor
First posted
Apr 26, 2016
Start date
Oct 2014
Primary completion
Aug 2015
Completion
Apr 2016
Last update
Apr 27, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion